Holen Sie sich die Stockscreener-App
265.55
2.78%
7.18
Handel nachbörslich:
272.40
6.85
+2.58%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$258.37
Offen:
$261.71
24-Stunden-Volumen:
9.65M
Relative Volume:
0.91
Marktkapitalisierung:
$331.61B
Einnahmen:
$20.56B
Nettoeinkommen (Verlust:
$6.21B
KGV:
54.43
EPS:
4.8791
Netto-Cashflow:
$6.22B
1W Leistung:
+0.15%
1M Leistung:
+16.29%
6M Leistung:
+88.00%
1J Leistung:
+318.32%
1-Tages-Spanne:
$257.40
$266.14
1-Wochen-Bereich:
$256.71
$268.76
52-Wochen-Spanne:
$66.34
$273.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
265.55 | 322.64B | 20.56B | 6.21B | 6.22B | 4.8791 |
ASML
Asml Holding Nv
|
1,443.66 | 562.31B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
403.48 | 312.94B | 28.21B | 7.84B | 6.19B | 9.7629 |
KLAC
Kla Corp
|
1,812.06 | 234.02B | 12.74B | 4.56B | 4.38B | 34.42 |
TER
Teradyne Inc
|
385.18 | 59.48B | 3.19B | 554.05M | 450.41M | 3.483 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Universal Beteiligungs und Servicegesellschaft mbH Sells 98,734 Shares of Lam Research Corporation $LRCX - MarketBeat
KLP Kapitalforvaltning AS Sells 13,000 Shares of Lam Research Corporation $LRCX - MarketBeat
Is Lam Research Corporation (LRCX) eyeing Besi Industries merger amid IBM pact for logic scaling - MSN
5 Top Earnings Charts to Watch This Week - TradingView
Lam Research (LRCX) Prepares for Q3 Earnings with Strong Expecta - GuruFocus
Lam Research Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
As Lam Research Joins the Tesla Terafab, Should You Buy, Sell, or Hold LRCX Stock? - Barchart.com
PFG Advisors Has $4.24 Million Stake in Lam Research Corporation $LRCX - MarketBeat
LAM RESEARCH CORP (NASDAQ:LRCX) Presents a High-Growth Momentum and Technical Breakout Opportunity - ChartMill
Musk’s Terafab taps Applied Materials, Tokyo Electron, Lam Research in chip push: report - MSN
Lam Research Corp. stock underperforms Monday when compared to competitors - MarketWatch
Lam Research Corp expected to post earnings of $1.36 a shareEarnings Preview - TradingView
Record‑High Stocks Dive Into Earnings Week With US-Iran Tensions on the Rise Again - Investing.com
Lam Research Corporation $LRCX Shares Sold by Krilogy Financial LLC - MarketBeat
Jim Cramer Believes Lam Research’s Upcoming Earnings “Could Be Explosive” - Insider Monkey
20 Stocks on Jim Cramer’s Game Plan, Including Tesla and Vertiv - Insider Monkey
Lam Research Corporation $LRCX Stake Lowered by Deroy & Devereaux Private Investment Counsel Inc. - MarketBeat
Deutsche Bank Raises its Price Target on Lam Research (LRCX) to $300 - Insider Monkey
Lam Research Corp stock (US5184391044): Is AI chip demand strong enough to unlock new upside? - AD HOC NEWS
Whittier Trust Co. Sells 3,981 Shares of Lam Research Corporation $LRCX - MarketBeat
MASTERINVEST Kapitalanlage GmbH Has $7.94 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Moran Wealth Management LLC Acquires 5,442 Shares of Lam Research Corporation $LRCX - MarketBeat
SMART Wealth LLC Sells 6,561 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by Merit Financial Group LLC - MarketBeat
Nations Financial Group Inc. IA ADV Purchases Shares of 7,203 Lam Research Corporation $LRCX - MarketBeat
GF Fund Management CO. LTD. Has $45.63 Million Position in Lam Research Corporation $LRCX - MarketBeat
Cwm LLC Boosts Position in Lam Research Corporation $LRCX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Asset Management One Co. Ltd. Raises Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research (LRCX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Increases Stake in Lam Research Corporation $LRCX - MarketBeat
Semiconductor ETFs Surge As AI Boom Powers Nvidia-Led Rally - Sahm
LRCX Stock Price, Quote & Chart | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
Lam Research (NASDAQ:LRCX) Shares Down 1.6%Should You Sell? - MarketBeat
GAM Holding AG's Lam Research Corp(LRCX) Holding History - GuruFocus
LAM RESEARCH CORPORATION (LRCX) - MSN
Musk asks suppliers to move at ‘light speed’ on Terafab project - Taipei Times
Lam Research Corporation $LRCX Shares Bought by Cornerstone Wealth Group LLC - MarketBeat
Musk Asks Suppliers to Move at ‘Light Speed’ on New Chipmaking Plan - Bloomberg
Farther Finance Advisors LLC Buys 19,254 Shares of Lam Research Corporation $LRCX - MarketBeat
KLA Corporation and Lam Research Shares Plummet, What You Need To Know - Yahoo Finance
Musk's staff reaches out to suppliers for Terafab project, Bloomberg News reports - Reuters
Lam Research Earnings Call Draws Market Focus - Kalkine Media
Lam Research Corp Stock (LRCX) Moved Down by 3.05% on Apr 15: Key Drivers Unveiled - TradingKey
Lam Research (LRCX) fuels bullish sentiment despite supply chain risks - MSN
Monument Capital Management Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
27,136 Shares in Lam Research Corporation $LRCX Acquired by Decker Retirement Planning Inc. - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Foster Victor Wealth Advisors LLC - MarketBeat
AB Growth Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research (NASDAQ:LRCX) Stock Price Up 1.9% Following Analyst Upgrade - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bettinger Douglas R | Chief Financial Officer & EVP |
Mar 04 '26 |
Sale |
224.03 |
50,057 |
11,214,270 |
1,081,705 |
| Harter Ava | Chief Legal Officer |
Mar 04 '26 |
Sale |
222.66 |
1,500 |
333,990 |
53,205 |
2.32%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):